Steadman Philippon Research Institute (SPRI) was founded in 1988 with a commitment to keeping people active through scientific research and education.
Did you know that the most common cause of disability in the United States is lower back pain? Or that over 126.6 million Americans are currently afflicted with musculoskeletal diseases like arthritis? Although you may not hear about orthopaedic conditions often, the burden of these diseases exceeds cancer by 6 times, and causes $213 billion in treatment costs and lost wages every year in the United States alone.
At SPRI, we’re on a mission to solve this problem.
For years, SPRI has been on the forefront of discovering new treatments for orthopaedic conditions with the goal of finding cures. Right now, SPRI is underway on several clinical trials focused on improving healing, and with its clinical partner The Steadman Clinic, SPRI is accelerating getting these treatments to patients faster. Our goal is to help people of all ages stay active in their daily lives, from recreationists to professional and Olympic athletes.
With a focus on collaborative, team science, SPRI is comprised of distinct departments that work together to conduct leading-edge research. These departments include the Linda & Mitch Hart Center for Regenerative and Personalized Medicine, the Department of Biomedical Engineering, the Center for Outcomes-Based Orthopaedic Research and the Department of Education.
SPRI’s close relationship with The Steadman Clinic has enabled the institute to make key discoveries to optimize healing from surgery with therapeutics. With a strong base in orthopaedic applications, SPRI is now expanding its research to other age-related diseases, like cancer. The goal of these new programs is to take SPRI and The Steadman Clinic’s expertise in orthopaedic surgical optimization and use similar approaches for cancer patients undergoing radiation or surgical treatment.